Add time:08/19/2019         Source:sciencedirect.com

The present study examined the roles of ventrolateral orbital cortex (VLO) 5-HT1, 5-HT2, 5-HT3, 5-HT4, 5-HT5, 5-HT6 and 5-HT7 receptor subtypes in mediating 5-HT-induced antiallodynic actions in the rat spared nerve injury (SNI) pain model. Changes in paw withdrawal threshold (PWT) were measured using von-Frey filaments. Microinjection of 5-HT (2, 5 and 10 μg, in 0.5 μl) into the VLO depressed allodynia induced by SNI, and the PWT increased in a dose-dependent manner. Microinjection of selective 5-HT1A, 5-HT2, 5-HT3, 5-HT4, 5-HT5A, 5-HT6 and 5-HT7 receptor antagonists, 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine hydrobromide (NAN-190) (10 μg), cyproheptadine (50 ng), granisetron hydrochloride (granisetron) (10 μg), 1-[2-[(methylsulfonyl)-amino]ethyl]-4-piperidinyl]methyl1-methyl-1H-indole-3-carboxylate (GR113808) (5 μg), SB699551 dihydrochloride (SB699551) (10 μg), SB258585 dihydrochloride (SB258585) (2 μg) or SB269970 hydrochloride (SB269970) (10 μg) into the VLO 5-min prior to 5-HT (10 μg) injection, all antagonized the 5-HT-induced inhibition of allodynia. In addition, these antagonists applied alone to VLO did not influence allodynia. These results suggest that although 5-HT1–7 receptor subtypes in the VLO do not have a tonic modulatory action on the allodynia induced by SNI, they are involved in mediating the depression of the SNI allodynia produced by injection of 5HT into VLO.

We also recommend Trading Suppliers and Manufacturers of 1-(2-Methoxyphenyl)piperazine hydrobromide (cas 100939-96-6). Pls Click Website Link as below: cas 100939-96-6 suppliers